HomeCompareEMHTF vs XYLD

EMHTF vs XYLD: Dividend Comparison 2026

EMHTF yields 4938.27% · XYLD yields 11.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMHTF wins by $55146348937607.22M in total portfolio value
10 years
EMHTF
EMHTF
● Live price
4938.27%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55146348937607.24M
Annual income
$53,033,758,961,414,200,000.00
Full EMHTF calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
11.20%
Share price
$38.36
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$3,351.03
Full XYLD calculator →

Portfolio growth — EMHTF vs XYLD

📍 EMHTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMHTFXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMHTF + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMHTF pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMHTF
Annual income on $10K today (after 15% tax)
$419,753.09/yr
After 10yr DRIP, annual income (after tax)
$45,078,695,117,202,070,000.00/yr
XYLD
Annual income on $10K today (after 15% tax)
$952.37/yr
After 10yr DRIP, annual income (after tax)
$2,848.38/yr
At 15% tax rate, EMHTF beats the other by $45,078,695,117,202,070,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMHTF + XYLD for your $10,000?

EMHTF: 50%XYLD: 50%
100% XYLD50/50100% EMHTF
Portfolio after 10yr
$27573174468803.63M
Annual income
$26,516,879,480,707,100,000.00/yr
Blended yield
96.17%
📊

Analyst Conviction Gap

Where Wall Street is split right now

EMHTF
Analyst Ratings
1
Hold
Consensus: Hold
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMHTF buys
0
XYLD buys
0
No recent congressional trades found for EMHTF or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMHTFXYLD
Forward yield4938.27%11.20%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$55146348937607.24M$25.9K
Annual income after 10y$53,033,758,961,414,200,000.00$3,351.03
Total dividends collected$55003355952995.54M$20.2K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: EMHTF vs XYLD ($10,000, DRIP)

YearEMHTF PortfolioEMHTF Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$504,527$493,827.16$10,840$1,120.44+$493.7KEMHTF
2$23,824,817$23,284,973.37$11,786$1,249.59+$23.81MEMHTF
3$1,053,123,085$1,027,630,530.32$12,854$1,397.78+$1053.11MEMHTF
4$43,579,292,978$42,452,451,277.21$14,063$1,568.33+$43579.28MEMHTF
5$1,688,429,051,261$1,641,799,207,774.13$15,434$1,765.19+$1688429.04MEMHTF
6$61,254,845,187,941$59,448,226,103,092.12$16,995$1,993.14+$61254845.17MEMHTF
7$2,081,181,684,947,090$2,015,639,000,595,993.00$18,777$2,257.95+$2081181684.93MEMHTF
8$66,229,598,087,621,200$64,002,733,684,727,816.00$20,818$2,566.58+$66229598087.60MEMHTF
9$1,974,383,155,320,608,300$1,903,517,485,366,853,600.00$23,163$2,927.50+$1974383155320.59MEMHTF
10$55,146,348,937,607,240,000$53,033,758,961,414,200,000.00$25,865$3,351.03+$55146348937607.22MEMHTF

EMHTF vs XYLD: Complete Analysis 2026

EMHTFStock

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. As of November 10, 2022, Emerald Health Therapeutics, Inc. operates as a subsidiary of Skye Bioscience, Inc.

Full EMHTF Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this EMHTF vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMHTF vs SCHDEMHTF vs JEPIEMHTF vs OEMHTF vs KOEMHTF vs MAINEMHTF vs QYLDEMHTF vs JEPQEMHTF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.